Influenza Vaccine Market Opportunities and Challenges: Worldwide Forecast
Renub Research (http://renub.com/reports/showdetails.aspx?id=53) has announced the addition of the "Influenza Vaccine Market Opportunities and Challenges: Worldwide Forecast" report to its offering
Online PR News – 26-October-2012 – Roswell, Georgia – Last few years have seen renewed interest in the vaccines market, overcoming the prevailing view that vaccines are a low-margin business with high barriers to entry. The flu vaccines market has been at the forefront of this trend, partially fuelled by the fear of an impending pandemic. As a result global influenza vaccine market has experienced phenomenal growth in recent years at a compound annual growth rate of more than 65% between 2008 and 2010. This growth was mainly driven by the global spread of H1N1 influenza. But in the year 2011 H1N1 pandemic flu vaccine market declined due to waning threat of swine flu disease. However seasonal influenza vaccine market is predicted to grow year on year and cross US$ 4 Billion by 2015.
From our research findings Unites States is the largest market for influenza vaccine market in 2010. In seasonal influenza vaccine brands like Fluarix & Flulaval had highest sales for 2010. Unlike some other pharmaceutical products, influenza vaccines are equally important in both developed and developing nations. In the developing countries, dealing with infectious diseases remains the highest priority in healthcare. It is predicted that in the next 5-6 years seasonal influenza vaccine sales would increase significantly.
Renub Research report entitled “Influenza Vaccine Market Opportunities and Challenges: Worldwide Forecast” critically examines the influenza vaccines market through a comprehensive review of information. This report provides market prospects, Key products detailed sales forecasts, discussions of pipeline developments and analyses of commercial drivers and challenges, including revenue of key players from seasonal and H1N1 influenza vaccine as well as Strengths and Weakness analysis of key players in influenza vaccine segment.
• Global Influenza vaccine market (2005 - 2015)
This section covers the key facts about the major companies that play an important role in Influenza Vaccine Market. The companies analyzed in this section are – GlaxoSmithKline, AstraZeneca, Novartis AG and Sanofi Pasteur. All the companies have been analyzed from three headings
1) Revenue of the company from influenza vaccines (swine flu & seasonal flu)
Click here to view the report details: http://renub.com/reports/showdetails.aspx?id=53
For more information visit: http://www.renub.com/
Related Reports: http://www.renub.com/reports/showdetails.aspx?id=81
Copyright 2014 Online PR Media | PO Box 5043 | La Quinta, CA 92248